Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers

• Anlin Li,
• Yongjian Chen,
• Wenda Zhang,
• Haitao Zhong,
• Qiyun Ou,
• Yang Gu,
• Junqing Xia,
• Dagui Lin,
• Tuping Fu,
• Ruixin Liu,
• Hai Hu,
• Yunfang Yu,
• Herui Yao

Affiliations

Anlin Li

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Yongjian Chen

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Wenda Zhang

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Haitao Zhong

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Qiyun Ou

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Yang Gu

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Junqing Xia

The First Clinical Medical College Southern Medical University Guangzhou China

Dagui Lin

Sun Yat‐sen University Cancer Center Guangzhou China

Tuping Fu

Sun Yat‐sen University Cancer Center Guangzhou China

Ruixin Liu

Guangdong Key Laboratory for Research and Development of Natural Drugs Guangdong Medical University Zhanjiang China

Hai Hu

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Yunfang Yu

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Herui Yao

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China